Caliway Biopharmaceuticals Co., Ltd. (TPE:6919)
Taiwan · Delayed Price · Currency is TWD 81.60
-3.60 (-4.23%)
Sep 8, 2026, 1:30 PM CST
TPE:6919 Market Cap
TPE:6919 has a market cap or net worth of 132.52 billion as of September 4, 2026. Its market cap has decreased by -66.49% in one year.
Market Cap
132.52B
Enterprise Value
128.58B
Revenue
29.39M
Ranking
n/a
PE Ratio
n/a
Stock Price
81.60
ChartMarket Cap Chart
Since December 26, 2022, TPE:6919's market cap has increased from 7.96B to 132.52B, an increase of 1,565.16%. That is a compound annual growth rate of 113.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 7, 2026 | 132.52B | -44.84% |
| Dec 31, 2025 | 240.25B | 154.60% |
| Dec 31, 2024 | 94.36B | 300.87% |
| Dec 29, 2023 | 23.54B | 212.69% |
| Dec 30, 2022 | 7.53B | -5.41% |
| Dec 26, 2022 | 7.96B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Lin BioScience | 144.70B |
| Pell Bio-Med Technology | 87.93B |
| Oneness Biotech | 21.87B |
| CHO Pharma | 21.83B |
| Sunmax Biotechnology | 21.46B |
| Medigen Vaccine Biologics | 20.84B |
| TaiMed Biologics | 17.13B |
| Gongwin Biopharm Holdings | 16.36B |